Documents by this lawyer on Martindale.com
Federal Circuit's Unanimous En Banc Decision Focuses on "Attribution to a Single Entity" to Establish Divided-Infringement Liability
Gregory A. Castanias,Anthony M. Insogna,David M. Maiorana,Sasha Mayergoyz,Matthew J. Silveira, August 17, 2015
On August 13, 2015, the Federal Circuit issued an en banc decision in Akamai Technologies, Inc. v. Limelight Networks, Inc., stating in a per curiam opinion that "we unanimously set forth the law of divided infringement under 35 U.S.C. § 271(a)." In doing so, the court held that...
Patent Litigants Feeling Effects of Teva in Claim Construction Decisions on Appeal
Gregory A. Castanias,Anthony M. Insogna,Sasha Mayergoyz,Jennifer L. Swize, July 15, 2015
In January 2015, the U.S. Supreme Court handed down its decision in Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., holding that underlying factual disputes related to a district court's claim construction should be reviewed for clear error instead of de novo, as the Federal Circuit had long held....
Federal Circuit Upholds Invalidity of Prenatal DNA Test Patent Under 35 U.S.C. §101
Gregory A. Castanias,J. Patrick Elsevier,Anthony M. Insogna,Kelsey I. Nix,Astrid R. Spain, June 24, 2015
In its June 12, 2015 opinion in Ariosa Diagnostics, Inc. v. Sequenom, Inc., the U.S. Court of Appeals for the Federal Circuit held that Sequenom's patent directed to methods of detecting fetal DNA in a pregnant woman's plasma or serum, although "a positive and valuable contribution to...